The Vaccines and Emerging Infections Subcommittees present a three-part webinar series to explore the evidence, development and implementation of vaccines for Bundibugyo ebolavirus disease.
Through expert presentations and facilitated discussion, participants will examine emerging data on cross-protection, advances in clinical development, and the practical challenges of vaccine deployment, providing timely context ahead of the October SAGE meeting on Ebola vaccines.
Save the date for the webinars below. More information on the programme and links to register will be coming soon!
Evidence of cross-protection against BDBV following vaccination against Zaire ebolavirus
Chairs: Folake Olayinka (Africa CDC), Hanna Nohynek (Finnish Institute for Health and Welfar, ESCMID Vaccines Subcommittee), Xavier Lescure (APHP Hôpital Bichat, ESCMID Emerging Infections Subcommittee)
14:00-14:05 Introduction
14:05-14:20 Readiness and lessons from DRC ebola and West Africa ebola and mpox – Africa CDC, TBA
14:20-14:35 Vaccine readiness for approved vaccine roll-out: field lessons and practical considerations – Ministry of Health of DRC, TBA
14:35-14:50 Preparing for BDBV vaccination: norms, guidance and tools for integrating vaccination into outbreak response – Reena Hemendra Dosi (WHO AFRO)
14:50-15:05 Behavioural and community readiness for BDBV vaccination: evidence, emerging concerns and response strategies - Deepa Risal Pokharel (UNICEF)
15:05-15:20 Regulatory preparedness for BDBV vaccines – African Medical Agency, TBA
